JRSS (JRSIS Health Care) Research & Development: $0.04 Mil (TTM As of Mar. 2025)


What is JRSIS Health Care Research & Development?

JRSIS Health Care JRSS -39.67% Research & Development is $0.04 Mil as of Mar. 2025.

Research & Development is the aggregate amount of research and development expenses during the year. JRSIS Health Care's Research & Development for the three months ended in Mar. 2025 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was $0.04 Mil.

JRSIS Health Care  (OTCPK:JRSS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

JRSIS Health Care Research & Development Related Terms

JRSIS Health Care Research & Development Historical Data

* Premium members only.

The historical data trend for JRSIS Health Care's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JRSIS Health Care Research & Development Chart

JRSIS Health Care Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.28 0.19 0.05

JRSIS Health Care Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.03 0.00 0.00

JRSIS Health Care Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.04 Mil mean?
JRSIS Health Care (JRSS) has a Research & Development of $0.04 Mil as of Mar. 2025. Research and development expense is the total cost for research and development activities. View historical data on JRSIS Health Care and its competitors.
Is JRSIS Health Care's Research & Development too high?
JRSIS Health Care's current Research & Development is $0.04 Mil.
How does JRSIS Health Care's Research & Development compare to NVVE and FTEL?
JRSIS Health Care's Research & Development of $0.04 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Retail - Cyclical company?
A good Research & Development depends on the Retail - Cyclical industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on JRSIS Health Care and its competitors. JRSIS Health Care's current Research & Development is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JRSIS Health Care stock overvalued right now?
JRSIS Health Care (JRSS) has a current Research & Development of $0.04 Mil. The current Research & Development is $0.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For JRSIS Health Care (JRSS), the current Research & Development is $0.04 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

JRSIS Health Care Business Description

Address Yongzhou Economic and Technology Development Zone, Building 2, Youth Innovation and Entrepreneurship Park, Xiaoxiang Science and Technology Innovation Center, Hunan Province, Yongzhou, CHN, 425000
JRSIS Health Care Corp, through its subsidiaries, is mainly engaged in providing charging services to electric vehicles incorporated in Zhongshan City of Guangdong, China.